By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ariad Pharmaceuticals, Inc. 

26 Landsdowne Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-494-0400 Fax: 617-494-8144


ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit or follow ARIAD on Twitter (@ARIADPharm).

Key Statistics

Ownership: Public

Web Site: Ariad
Symbol: ARIA

Company News
Ariad (ARIA) Announces Regulatory Approval For Iclusig (Ponatinib) In Japan 9/28/2016 11:23:42 AM
Ariad (ARIA) Announces Ponatinib Data Presentations At European School Of Hematology Annual John Goldman Conference On Chronic Myeloid Leukemia 9/15/2016 10:55:59 AM
Ariad (ARIA) Completes Rolling Submission Of New Drug Application For Brigatinib To The FDA 8/30/2016 1:05:08 PM
Ariad (ARIA) To Present At The Morgan Stanley Global Healthcare Conference 8/29/2016 10:20:40 AM
PDL BioPharma (PDLI) Completes Second Tranche Payment Under Royalty Transaction With Ariad (ARIA) 8/2/2016 9:05:35 AM
Ariad (ARIA) Reports Second Quarter And First Half 2016 Financial Results 7/28/2016 11:38:15 AM
Ariad (ARIA) To Webcast Conference Call On Second Quarter 2016 Financial Results 7/5/2016 8:21:11 AM
Ariad (ARIA) Announces Webcast Of Its Annual Stockholders Meeting 6/24/2016 7:44:15 AM
Ariad (ARIA) Completes Strategic Review And Announces Plans For Growth 6/20/2016 11:40:57 AM
Ariad (ARIA) Completes Strategic Review And Announces Plans For Growth 6/17/2016 10:41:37 AM